Abstract
The nervous system may be involved in up to 30% of patients with Sjogren’s syndrome (SS). We describe three patients with Sjogren’s syndrome and a concomitant parkinsonian syndrome. Elevated titers of anti-β2-glycoprotein I IgG were found in the serum of all three patients. This autoantibody is strongly associated with anticardiolipin (aCL) antibodies, antiphospholipid syndrome (APS), and thromboembolic phenomena, but its role in the pathogenesis of the parkinsonian disorder in SS is unclear. These patients may present a subtype of SS patients in which the presence of aCL antibodies is associated with central nervous system involvement predominantly in the basal ganglia.
Similar content being viewed by others
References
Alexander E (1992) Central nervous system disease in Sjogren’s syndrome. New insights into immunopathogenesis. Rheum Dis Clin North Am 18(3):637–672
Nishimura H, Tachibana H, Makiura N, Okuda B, Sugita M (1994) Corticosteroid-responsive parkinsonism associated with primary Sjogren’s syndrome. Clin Neurol Neurosurg 96(4):327–331
Creange A, Sedel F, Brugieres P, Voisin MC, Degos JD (1997) Primary Sjogren’s syndrome presenting as progressive parkinsonian syndrome. Mov Disord 12(1):121–123
Fabre N, Faucheux J, Roland Y, Cantagrel A, Geraud G (1996) Corticosteroid-responsive parkinsonism associated with primary Sjogren’s syndrome: Report of two cases (abstract). Neurology 46:A299
Hashimoto S, Sawada T, Inoue T, Yamamoto K, Iwata M (1999) Cholinergic-drug induced sicca syndrome in Parkinson’s disease: a case report and a review of the literature. Clin Neurol Neurosurg 101(4):268–270
Miyoshi Y, Atsumi T, Kitagawa H, Ogura N, Amasaki Y, Tsutsumi A et al (1993) Parkinson-like symptoms as a manifestation of systemic lupus erythematosus. Lupus 2(3):199–201
Walker RH, Spiera H, Brin MF, Olanow CW (1999) Parkinsonism associated with Sjogren’s syndrome: three cases and a review of the literature. Mov Disord 14(2):262–268
Visser LH, Koudstaal PJ, van de Merwe JP (1993) Hemiparkinsonism in a patient with primary Sjogren’s syndrome. A case report and a review of the literature. Clin Neurol Neurosurg 95(2):141–145
Vitali C, Bombardieri S, Moutsopoulos HM, Coll J, Gerli R, Hatron PY et al (1996) Assessment of the European classification criteria for Sjogren’s syndrome in a series of clinically defined cases: results of a prospective multicenter study. The European Study Group on Diagnostic Criteria for Sjogren’s Syndrome. Ann Rheum Dis 55(2):116–121
Alexander EL (1993) Neurologic disease in Sjogren’s syndrome: mononuclear inflammatory vasculopathy affecting central/peripheral nervous system and muscle. A clinical review and update of immunopathogenesis. Rheum Dis Clin North Am 19(4):869–908
Greco TP, Amos MD, Conti-Kelly AM, Naranjo JD, Ijdo JW (2000) Testing for the antiphospholipid syndrome: importance of IgA anti-beta 2-glycoprotein I. Lupus 9(1):33–41
Osawa H, Yamabe H, Kaizuka M, Tamura N, Tsunoda S, Shirato KI et al (1997) Systemic lupus erythematosus associated with transverse myelitis and parkinsonian symptoms. Lupus 6(7):613–615
Mochizuki H, Okano M, Masaki T, Nagata N, Kamakura K (1997) A case of Sjogren’s syndrome with a high titer of anticardiolipin antibody that developed as parkinsonism. Rinsho Shinkeigaku 37(1):57–59
Shahar E, Goshen E, Tauber Z, Lahat E (1998) Parkinsonian syndrome complicating systemic lupus erythematosus. Pediatr Neurol 18(5):456–458
Inanc M, Donohoe S, Ravirajan CT, Radway-Bright EL, Mackie I, Machin S et al (1998) Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome. Br J Rheumatol 37(10):1089–1094
Merkel PA, Chang Y, Pierangeli SS, Convery K, Harris EN, Polisson RP (1996) The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases. Am J Med 101(6):576–583
Pennec YL, Magadur G, Jouquan J, Youinou P (1991) Serial measurements of anticardiolipin antibodies in primary Sjogren’s syndrome. Clin Exp Rheumatol 9(2):165–167
Cervera R, Garcia-Carrasco M, Font J, Ramos M, Reverter JC, Munoz FJ et al (1997) Antiphospholipid antibodies in primary Sjogren’s syndrome: prevalence and clinical significance in a series of 80 patients. Clin Exp Rheumatol 15(4):361–365
Jedryka-Goral A, Jagiello P, D’Cruz DP, Maldykowa H, Khamashta MA, Hughes GR et al (1992) Isotype profile and clinical relevance of anticardiolipin antibodies in Sjogren’s syndrome. Ann Rheum Dis 51(7):889–891
Verrotti A, Cieri F, Pelliccia P, Morgese G, Chiarelli F (2000) Lack of association between antiphospholipid antibodies and migraine in children. Int J Clin Lab Res 30(2):109–111
Tietjen GE, Day M, Norris L, Aurora S, Halvorsen A, Schultz LR et al (1998) Role of anticardiolipin antibodies in young persons with migraine and transient focal neurologic events: a prospective study. Neurology 50(5):1433–1440
Pal B, Gibson C, Passmore J, Griffiths ID, Dick WC (1989) A study of headaches and migraine in Sjogren’s syndrome and other rheumatic disorders. Ann Rheum Dis 48(4):312–316
Caronti B, Calderaro C, Alessandri C, Conti F, Tinghino R, Pini C et al (1998) Serum anti-beta2-glycoprotein I antibodies from patients with antiphospholipid antibody syndrome bind central nervous system cells. J Autoimmun 11(5):425–429
Brunella C, Valerio P, Guido P, Guido V (1998) Anti-b -glycoprotein I antibodies bind to central nervous system. J Neurol Sci 156:211–219
Shoenfeld Y, Nahum A, Korczyn AD, Dano M, Rabinowitz R, Beilin O, Pick CG, Leider-Trejo L, Kalashnikova L, Blank M, Chapman J (2003) Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer. Lupus 12:436–442
Shrot S, Katzav A, Korczyn AD, Litvinjuk Y, Hershenson R, Pick CG, Blank M, Zaech J, Shoenfeld Y, Sirota P, Chapman J (2002) Behavioral and cognitive deficits occur only after prolonged exposure of mice to antiphospholipid antibodies. Lupus 11:736–743
Author information
Authors and Affiliations
Corresponding author
Additional information
Sharon Hassin-Baer and Levy Yair contributed equally to this work.
Rights and permissions
About this article
Cite this article
Hassin-Baer, S., Levy, Y., Langevitz, P. et al. Anti-β2-glycoprotein I in Sjogren’s syndrome is associated with parkinsonism. Clin Rheumatol 26, 743–747 (2007). https://doi.org/10.1007/s10067-006-0398-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-006-0398-8